Cancer treatment research will take less time and be safer to carry out using a new test, say researchers.
The new testing procedure takes freshly-cultivated tissue from cancer patients and allows scientists to use it to estimate whether that person will respond to certain treatments.
Dr Ilona Schonn, director of cell culture research at Indivumed, pointed out that it will be useful to pharmaceutical companies as they will have reliable research on which drugs can be used most commonly.
But she noted that it will also make clinical trials more efficient and safer for patients.
"Together with all the clinical patient data and several analytical test systems such as signalling pathway analysis, we have been able to characterise individual tumours in more detail," said Dr Schonn.
The test can also be used to identify certain areas of the body which may be susceptible to treatment.
This week, Dr Christiane Voit from the Medical University of Berlin announced that patterns of ultrasounds can be used to work out if a cancerous tumour cell had started to spread.